Literature DB >> 20549407

Primary hyperoxaluria in a compound heterozygote infant.

Juan Mayordomo-Colunga1, Debora Riverol, Eduardo Salido, Fernando Santos.   

Abstract

BACKGROUND: Primary hyperoxaluria type 1 is a rare disorder caused by a defect in the hepatic metabolism of glyoxylate. Cases presenting in infancy are very uncommon and often have a severe course leading to early end-stage renal failure.
METHODS: We treated a case of early presentation of primary hyperoxaluria type 1 and reviewed the relevant literature.
RESULTS: A 4-month-old female infant was admitted to our hospital because of acute renal failure and nephrocalcinosis. Mutational analysis of alanine-glyoxylate aminotransferase gene revealed compound heterozygosity in the infant, confirming the development of primary hyperoxaluria type 1. A few weeks later, the condition of the infant worsened during an interdialytic period and died.
CONCLUSIONS: Interest of this case is based on the coexistence of two mutations of alanine-glyoxylate aminotransferase gene recently reported, and it confirms the severe course of the disease when it presents in infancy. It also highlights the importance of the association of nephrocalcinosis and urolithiasis as key diagnostic manifestations of primary hyperoxaluria type 1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549407     DOI: 10.1007/s12519-010-0214-z

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  13 in total

Review 1.  Primary hyperoxaluria type 1.

Authors:  P Cochat
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

2.  A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004.

Authors:  Neville V Jamieson
Journal:  Am J Nephrol       Date:  2005-06-15       Impact factor: 3.754

Review 3.  The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.

Authors:  C J Danpure
Journal:  J Nephrol       Date:  1998 Mar-Apr       Impact factor: 3.902

4.  Characterization and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase.

Authors:  P E Purdue; M J Lumb; M Fox; G Griffo; C Hamon-Benais; S Povey; C J Danpure
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

5.  Primary hyperoxaluria type 1: improved outcome with timely liver transplantation: a single-center report of 36 children.

Authors:  R Shapiro; I Weismann; H Mandel; B Eisenstein; Z Ben-Ari; N Bar-Nathan; I Zehavi; G Dinari; E Mor
Journal:  Transplantation       Date:  2001-08-15       Impact factor: 4.939

6.  Identification of 5 novel mutations in the AGXT gene.

Authors:  O Basmaison; M O Rolland; P Cochat; D Bozon
Journal:  Hum Mutat       Date:  2000-06       Impact factor: 4.878

7.  [Infantile forms of primary hyperoxaluria type I: apropos of 4 cases].

Authors:  A Kamoun; F Ben Moussa; H Ben Maiz; R Lakhoua
Journal:  Arch Pediatr       Date:  1996-10       Impact factor: 1.180

8.  Reference values of plasma oxalate in children and adolescents.

Authors:  Tadeusz Porowski; Walentyna Zoch-Zwierz; Jerzy Konstantynowicz; Agata Korzeniecka-Kozerska; Joanna Michaluk-Skutnik; Halina Porowska
Journal:  Pediatr Nephrol       Date:  2008-06-26       Impact factor: 3.714

9.  Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.

Authors:  Jinlan Jiang; Eduardo C Salido; Chandan Guha; Xia Wang; Rituparna Moitra; Laibin Liu; Jayanta Roy-Chowdhury; Namita Roy-Chowdhury
Journal:  Transplantation       Date:  2008-05-15       Impact factor: 4.939

10.  Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I.

Authors:  C J Danpure; P R Jennings
Journal:  FEBS Lett       Date:  1986-05-26       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.